BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 11854876)

  • 1. Heparin-bonded cardiopulmonary bypass circuits reduce cognitive dysfunction.
    Heyer EJ; Lee KS; Manspeizer HE; Mongero L; Spanier TB; Caliste X; Esrig B; Smith C
    J Cardiothorac Vasc Anesth; 2002 Feb; 16(1):37-42. PubMed ID: 11854876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac surgical patients exposed to heparin-bonded circuits develop less postoperative cerebral dysfunction than patients exposed to non-heparin-bonded circuits.
    Mongero LB; Beck JR; Manspeizer HE; Heyer EJ; Lee K; Spanier TA; Smith CR
    Perfusion; 2001 Mar; 16(2):107-11. PubMed ID: 11334193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biocompatibility of poly2methoxyethylacrylate coating for cardiopulmonary bypass.
    Noguchi M; Eishi K; Tada S; Yamachika S; Hazama S; Izumi K; Tanigawa K
    Ann Thorac Cardiovasc Surg; 2003 Feb; 9(1):22-8. PubMed ID: 12667126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and biomaterial evaluation of hyaluronan-based heparin-bonded extracorporeal circuits with reduced versus full systemic anticoagulation in reoperation for coronary revascularization.
    Gunaydin S; Farsak B; McCusker K; Vijay V; Sari T; Onur MA; Gurpinar A; Zorlutuna Y
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):135-42. PubMed ID: 19377380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory response after coronary revascularization: off-pump versus on-pump (heparin-coated circuits and poly2methoxyethylacrylate-coated circuits).
    Hazama S; Eishi K; Yamachika S; Noguchi M; Ariyoshi T; Takai H; Odate T; Matsukuma S; Onohara D; Yanatori M
    Ann Thorac Cardiovasc Surg; 2004 Apr; 10(2):90-6. PubMed ID: 15209550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limitation of thrombin generation, platelet activation, and inflammation by elimination of cardiotomy suction in patients undergoing coronary artery bypass grafting treated with heparin-bonded circuits.
    Aldea GS; Soltow LO; Chandler WL; Triggs CM; Vocelka CR; Crockett GI; Shin YT; Curtis WE; Verrier ED
    J Thorac Cardiovasc Surg; 2002 Apr; 123(4):742-55. PubMed ID: 11986603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombin generation during cardiopulmonary bypass using heparin-coated or standard circuits.
    Ernofsson M; Thelin S; Siegbahn A
    Scand J Thorac Cardiovasc Surg; 1995; 29(4):157-65. PubMed ID: 8789468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remote ischemic preconditioning prevents deterioration of short-term postoperative cognitive function after cardiac surgery using cardiopulmonary bypass: results of a pilot investigation.
    Hudetz JA; Patterson KM; Iqbal Z; Gandhi SD; Pagel PS
    J Cardiothorac Vasc Anesth; 2015 Apr; 29(2):382-8. PubMed ID: 25440646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of high-dose heparin on inflammatory and coagulation parameters following cardiopulmonary bypass.
    Paparella D; Al Radi OO; Meng QH; Venner T; Teoh K; Young E
    Blood Coagul Fibrinolysis; 2005 Jul; 16(5):323-8. PubMed ID: 15970715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete heparin-coated (CBAS) cardiopulmonary bypass and reduced systemic heparin dose; effects on coagulation and fibrinolysis.
    Ovrum E; Brosstad F; Am Holen E; Tangen G; Abdelnoor M; Oystese R
    Eur J Cardiothorac Surg; 1996; 10(6):449-55. PubMed ID: 8817142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic protein treated versus heparin coated cardiopulmonary bypass surfaces: similar clinical results and minor biochemical differences.
    Wimmer-Greinecker G; Matheis G; Martens S; Oremek G; Abdel-Rahman U; Moritz A
    Eur J Cardiothorac Surg; 1999 Aug; 16(2):211-7. PubMed ID: 10485423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin-coated cardiopulmonary bypass circuits in coronary bypass surgery.
    Horimoto H; Kondo K; Asada K; Sasaki S
    Artif Organs; 1996 Aug; 20(8):936-40. PubMed ID: 8853810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Closed cardiopulmonary bypass circuits suppress thrombin generation during coronary artery bypass grafting.
    Nakahira A; Sasaki Y; Hirai H; Fukui T; Matsuo M; Takahashi Y; Kotani S; Suehiro S
    Interact Cardiovasc Thorac Surg; 2010 Apr; 10(4):555-60. PubMed ID: 20061337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression changes in leukocytes during cardiopulmonary bypass are dependent on circuit coating.
    Seeburger J; Hoffmann J; Wendel HP; Ziemer G; Aebert H
    Circulation; 2005 Aug; 112(9 Suppl):I224-8. PubMed ID: 16159821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reducing the post-pump syndrome by using heparin-coated circuits, steroids, or aprotinin.
    Harig F; Feyrer R; Mahmoud FO; Blum U; von der Emde J
    Thorac Cardiovasc Surg; 1999 Apr; 47(2):111-8. PubMed ID: 10363611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin-coated circuits reduce myocardial injury in heart or heart-lung transplantation: a prospective, randomized study.
    Wan S; LeClerc JL; Antoine M; DeSmet JM; Yim AP; Vincent JL
    Ann Thorac Surg; 1999 Oct; 68(4):1230-5. PubMed ID: 10543484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy of heparin-bonded bypass circuits related to cytokine responses in children.
    Ozawa T; Yoshihara K; Koyama N; Watanabe Y; Shiono N; Takanashi Y
    Ann Thorac Surg; 2000 Feb; 69(2):584-90. PubMed ID: 10735703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin bonding of bypass circuits reduces cytokine release during cardiopulmonary bypass.
    Steinberg BM; Grossi EA; Schwartz DS; McLoughlin DE; Aguinaga M; Bizekis C; Greenwald J; Flisser A; Spencer FC; Galloway AC
    Ann Thorac Surg; 1995 Sep; 60(3):525-9. PubMed ID: 7677475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin-coated bypass circuits (Carmeda) suppress the release of tissue plasminogen activator during normothermic coronary artery bypass graft surgery.
    Spiess BD; Vocelka C; Cochran RP; Soltow L; Chandler WL
    J Cardiothorac Vasc Anesth; 1998 Jun; 12(3):299-304. PubMed ID: 9636912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biocompatibility of heparin-coated cardiopulmonary bypass circuits in coronary patients with left ventricular dysfunction is superior to PMEA-coated circuits.
    Kutay V; Noyan T; Ozcan S; Melek Y; Ekim H; Yakut C
    J Card Surg; 2006; 21(6):572-7. PubMed ID: 17073955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.